Syncom Formulations India Ltd posts Rs. 3.86 crores profit in Q1FY23

SYNCOM FORMULATIONS (INDIA) LTD. has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 54.3801 crores during the period ended June 30, 2022 as compared to Rs. 63.9326 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 3.8676 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 4.7579 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 0.03 for the period ended June 30, 2022 as compared to Rs. 0.05 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 54.3801 crs	₹63.9326 crs	-14.94%
Net Profit	₹3.8676 crs	₹4.7579 crs	-18.71%
EPS	₹0.03	₹0.05	-40.00%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 54.3801 crores during the period ended June 30, 2022 as compared to Rs.52.5999 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.3.8676 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.5.3976 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.0.03 for the period ended June 30, 2022 as compared to Rs.0.07 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 54.3801 crs	₹52.5999 crs	3.38%
Net Profit	₹3.8676 crs	₹5.3976 crs	-28.35%
EPS	₹0.03	₹0.07	-57.14%

Shares of SYNCOM FORMULATIONS (INDIA) LTD. was last trading in BSE at Rs. 9.18 as compared to the previous close of Rs. 9.25. The total number of shares traded during the day was 1514945 in over 2374 trades.

The stock hit an intraday high of Rs. 9.35 and intraday low of 9.12. The net turnover during the day was Rs. 13902858.00.

Source : Equity Bulls

Keywords

SyncomFormulationsIndia Q4FY22 FY2022 ResultUpdate